M Zuber
Isolated tumor cells in stage I & II colon cancer patients are associated with significantly worse disease-free and overall survival
Weixler B, Warschkow R, Gueller U, Zettl A, von Holzen U, Schmied B, Zuber M. Isolated tumor cells in stage I & II colon cancer patients are associated with significantly worse disease-free and overall survival. BMC cancer 2016; 16:106.
16.02.2016Isolated tumor cells in stage I & II colon cancer patients are associated with significantly worse disease-free and overall survival
16.02.2016BMC cancer 2016; 16:106
Weixler B, Warschkow Rene, Gueller Ulrich, Zettl A, von Holzen U, Schmied B M, Zuber M
Molecular staging of lymph node-negative colon carcinomas by one-step nucleic acid amplification (OSNA) results in upstaging of a quarter of patients in a prospective, European, multicentre study
Croner R, Stürzl M, Gueller U, Tarragona J, Matias-Guiu X, Zettl A, Rosenberg R, Späth C, Nitsche U, Bader F, Geppert C, Zuber M. Molecular staging of lymph node-negative colon carcinomas by one-step nucleic acid amplification (OSNA) results in upstaging of a quarter of patients in a prospective, European, multicentre study. Br J Cancer 2014; 110:2544-50.
10.04.2014Molecular staging of lymph node-negative colon carcinomas by one-step nucleic acid amplification (OSNA) results in upstaging of a quarter of patients in a prospective, European, multicentre study
10.04.2014Br J Cancer 2014; 110:2544-50
Croner R S, Stürzl M, Gueller Ulrich, Tarragona J, Matias-Guiu X, Zettl A, Rosenberg R, Späth C, Nitsche U, Bader F G, Geppert C-I, Zuber M
The bumpy path to successful academic surgery: a roadmap for the surgical resident
Gueller U, Kempski O, Zuber M. The bumpy path to successful academic surgery: a roadmap for the surgical resident. Eur Surg Res 2009; 43:253-5.
23.07.2009The bumpy path to successful academic surgery: a roadmap for the surgical resident
23.07.2009Eur Surg Res 2009; 43:253-5
Gueller Ulrich, Kempski O, Zuber M
Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients
Langer I, Oertli D, Harder F, Wight E, Moch H, Viehl C, Ladewig A, Hsu-Schmitz S, Gueller U, Zuber M. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients. Eur J Surg Oncol 2008; 35:805-13.
28.11.2008Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients
28.11.2008Eur J Surg Oncol 2008; 35:805-13
Langer I, Oertli D, Harder F, Wight E, Moch H, Viehl C T, Ladewig A, Hsu-Schmitz S F, Gueller Ulrich, Zuber M
Long-term outcomes of breast cancer patients after endoscopic axillary lymph node dissection: a prospective analysis of 52 patients
Langer I, Kocher T, Gueller U, Torhorst J, Oertli D, Harder F, Zuber M. Long-term outcomes of breast cancer patients after endoscopic axillary lymph node dissection: a prospective analysis of 52 patients. Breast Cancer Res Treat 2005; 90:85-91.
01.03.2005Long-term outcomes of breast cancer patients after endoscopic axillary lymph node dissection: a prospective analysis of 52 patients
01.03.2005Breast Cancer Res Treat 2005; 90:85-91
Langer I, Kocher T, Gueller Ulrich, Torhorst J, Oertli D, Harder F, Zuber M